Silicasome Nanocarriers: Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo‐Immunotherapy (Small 14/2021)
Source abstract
Abstract
Effective delivery of activated oxaliplatin to pancreatic cancer achieved by a tailored silicasome nanocarrier is reported by Andre E. Nel, Huan Meng, and co-workers in article number 2005993. This provides a strong immunogenic cell death stimulus that turns the “cold” immunological status into “hot” at tumor site, enabling superior chemo-immunotherapy synergy with anti-PD-1.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Nanomedicine Department of Medicine University of California Los Angeles CA 90095 USA
California NanoSystems Institute University of California Los Angeles CA 90095 USA
Department of Physics and Astronomy University of California Los Angeles CA 90095 USA
References
Reference metadata was not supplied for this record.